PURAPHARM (01498) announced that Dr. Hong Tingan has been appointed as independent non-executive director, chairman of the board audit committee, member of the board remuneration committee, and member of the board nomination committee, effective from August 29, 2025.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.